Sign up to save your podcasts
Or
Share E137: Obexelimab in IgG4-RD (INDIGO)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E137: Obexelimab in IgG4-RD (INDIGO)
Another day, another B cell drug. This one adds an interesting option for IgG4-RD, offering a "maybe less efficacious maybe less toxic" pathway. I could see folks being excited for this, especially in a disease where non-scary-manifestations are relatively common.
Also, check out boardsbank.com!
Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2601337
View all episodes
By Michael Putman
4.9
114114 ratings
Another day, another B cell drug. This one adds an interesting option for IgG4-RD, offering a "maybe less efficacious maybe less toxic" pathway. I could see folks being excited for this, especially in a disease where non-scary-manifestations are relatively common.
Also, check out boardsbank.com!
Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2601337
More shows like The Evidence Based Rheumatology Podcast
View all
JAMA Clinical Reviews
506 Listeners
Mayo Clinic Talks
299 Listeners
Rheumnow Podcast
124 Listeners
The Curbsiders Internal Medicine Podcast
3,360 Listeners
Core IM | Internal Medicine Podcast
1,152 Listeners
Healio Rheuminations
120 Listeners
Annals On Call Podcast
197 Listeners
The Clinical Problem Solvers
517 Listeners
ACR on Air
68 Listeners
Around the Rheum with Drs. Daniel Ennis & Janet Pope
4 Listeners
The Curious Clinicians
373 Listeners
Rheumatology For The Royal College
182 Listeners
Febrile
188 Listeners
ACR Journals On Air
17 Listeners
Talking Rheumatology Spotlight
6 Listeners